Rallybio Corporation /
Avenzo Therapeutics, Inc.
Rallybio Corporation signed an agreement for Avenzo Therapeutics, Inc.
Source for the buyer and target: Rallybio Corporation
For the buyer and target.
“Rallybio Corporation, a Delaware corporation (“Rallybio”), and Avenzo Therapeutics, Inc., a Delaware corporation (“Avenzo”) have entered into an Agreement and Plan of Merger and Reorganization, dated May 31, 2026 (the “Merger Agreement”), pursuant to which, among other matters, Farmington Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Rallybio (“Merger Sub”), will merge with and into Avenzo, with Avenzo surviving as a wholly owned subsidiary of Rallybio (such transaction, the “Merger”).”
Published 14 Oct 2026
Open the sourceWhat happened
The deal for Avenzo Therapeutics, Inc. is signed, with Rallybio Corporation as the buyer. [01]
The filing from Rallybio Corporation is dated Oct. 14, 2026. [01]
Who is involved, and the source
Everything on this page comes from the source below, quoted word for word.
Advisers
Buy side
- Financial adviser to the buyerCitizensSource: SEC filing, as of 14 Oct 2026
Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.
Rallybio Corporation signed an agreement for Avenzo Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly